Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
4 hours ago•Business Standard
1 week ago•Business Standard
1 week ago•Bloomberg Quint
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 28, 2024. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report together with copy of minutes. | Download
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 28, 2024. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report together with copy of minutes. | Download
Final • Div/Share: ₹ 32
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant